Author:
Micheletti Robert G.,Chiesa-Fuxench Zelma,Noe Megan H.,Stephen Sasha,Aleshin Maria,Agarwal Ashwin,Boggs Jennifer,Cardones Adela R.,Chen Jennifer K.,Cotliar Jonathan,Davis Mark D.P.,Dominguez Arturo,Fox Lindy P.,Gordon Shayna,Hamrick Ronald,Ho Baran,Hughey Lauren C.,Jones Larry M.,Kaffenberger Benjamin H.,Kindley Kimball,Kroshinsky Daniela,Kwong Bernice Y.,Miller Daniel D.,Mostaghimi Arash,Musiek Amy,Ortega-Loayza Alex G.,Patel Raj,Posligua Alba,Rani Monica,Saluja Sandeep,Sharon Victoria R.,Shinkai Kanade,John Jessica St.,Strickland Nicole,Summers Erika M.,Sun Natalie,Wanat Karolyn A.,Wetter David A.,Worswick Scott,Yang Caroline,Margolis David J.,Gelfand Joel M.,Rosenbach Misha
Subject
Cell Biology,Dermatology,Molecular Biology,Biochemistry
Reference55 articles.
1. Treatment of toxic epidermal necrolysis with cyclosporin A;Arévalo;J Trauma,2000
2. SCORTEN: a severity of illness score for toxic epidermal necrolysis;Bastuji-Garin;J Invest Dermatol,2000
3. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme;Bastuji-Garin;Arch Dermatol,1993
4. High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis;Campione;Acta Derm Venereol,2003
5. Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review;Canavan;J Am Acad Dermatol,2015